Reports for ATNAHS PHARMA UK LIMITED
Company Name
ATNAHS PHARMA UK LIMITED
Totals |
||
Shortage reports |
17 |
|
| Actual shortage: | 8 (47%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 9 (53%) | |
Discontinuation Reports |
1 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 1 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
7 (39%) |
|
Overdue reports |
5 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANAPROX | 275MG | TABLET | Resolved | 2023-04-19 | 2023-05-26 | 189852 |
| ANAPROX | 275MG | TABLET | Actual shortage | 2024-07-10 | 2024-07-26 | 232627 |
| DIPENTUM | 250MG | CAPSULE | Actual shortage | 2022-12-06 | 2023-11-30 | 177181 |
| DIPENTUM | 250MG | CAPSULE | Actual shortage | 2023-03-31 | 2023-11-30 | 188443 |
| DIPENTUM | 250MG | CAPSULE | Resolved | 2023-06-05 | 2023-11-25 | 193760 |
| DIPENTUM | 250MG | CAPSULE | Actual shortage | 2023-07-19 | 2023-11-30 | 199211 |
| FAMVIR | 500MG | TABLET | Resolved | 2020-10-20 | 2021-08-12 | 126674 |
| FAMVIR | 250MG | TABLET | Resolved | 2020-10-20 | 2021-08-12 | 126668 |
| NAPROSYN | 750MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-01-18 | 2023-05-26 | 181466 |
| NAPROSYN | 750MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-10-02 | 2024-10-03 | 239149 |
| NAPROSYN | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-06-13 | 2018-09-21 | 52317 |
| NAPROSYN | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-26 | 2023-02-21 | 179465 |
| NAPROSYN | 500MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-02-28 | 2023-11-24 | 185677 |
| NAPROSYN | 500MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-09-21 | 2024-07-09 | 204887 |
| NAPROSYN | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-19 | 2023-05-26 | 189849 |
| SYNACTHEN DEPOT | 1MG | SUSPENSION | Actual shortage | 2019-01-15 | 2019-04-12 | 72327 |
| TORADOL IM | 10MG | SOLUTION | Resolved | 2020-07-14 | 2020-07-22 | 120334 |
Showing 1 to 17 of 17
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROSYN | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-07-10 | 2024-08-01 | 232646 |
Showing 1 to 1 of 1